Emerging in the arena of obesity treatment, retatrutide represents a distinct strategy. Beyond many existing medications, retatrutide works as a double agonist, simultaneously engaging both GLP peptide-1 (GLP-1) and https://siobhanhqjx550132.smblogsites.com/38753446/the-new-retatrutide-a-glp-gip-receptor-agonist